Evidence map›Paper›PMID 37358261›Full record

ReviewBioscience reports2023

Primase-polymerases: how to make a primer from scratch.

Lewis J Bainbridge, Katerina Zabrady, Aidan J Doherty

Open access · goldAbstract readReview
In one paragraph

Review in Bioscience reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lewis J BainbridgeGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN1 9RQ, U.K.ORCID 0000-0002-4037-9516
Katerina ZabradyGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN1 9RQ, U.K.ORCID 0000-0003-1946-0851
Aidan J DohertyGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN1 9RQ, U.K.ORCID 0000-0002-6370-1109
University of Sussex · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P007031/1Biotechnology and Biological Sciences Research Council BB/S008691/1Biotechnology and Biological Sciences Research Council BB/W015226/1Wellcome Trust
6 · The paper itself

Abstract

To pass on genetic information to the next generation, cells must faithfully replicate their genomes to provide copies for each daughter cell. To synthesise these duplicates, cells employ specialised enzymes called DNA polymerases, which rapidly and accurately replicate nucleic acid polymers. However, most polymerases lack the ability to directly initiate DNA synthesis and required specialised replicases called primases to make short polynucleotide primers, from which they then extend. Replicative primases (eukaryotes and archaea) belong to a functionally diverse enzyme superfamily known as Primase-Polymerases (Prim-Pols), with orthologues present throughout all domains of life. Characterised by a conserved catalytic Prim-Pol domain, these enzymes have evolved various roles in DNA metabolism, including DNA replication, repair, and damage tolerance. Many of these biological roles are fundamentally underpinned by the ability of Prim-Pols to generate primers de novo. This review examines our current understanding of the catalytic mechanisms utilised by Prim-Pols to initiate primer synthesis.

Indexed as

DNA-Directed DNA PolymeraseDNA PrimaseCatalytic DomainDNADNA ReplicationDNADNA-Directed DNA PolymeraseDNA PrimaseCAPPPri1primaseprimer initiationPrim-PolPrimPol

Identifiers

PMID37358261
PMCPMC10345425
OpenAlexW4382011861

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.